Pseudomonas aeruginosa infectious disease

This early-stage trial tests MP101, a mix of two viruses that attack bacteria (phages), in 18 adults with Pseudomonas aeruginosa pneumonia. Participants receive a single dose of MP101 or a placebo alongside standard antibiotics. The main goal is to check safety and how the body h…

This study looks at 600 adults with infections caused by a hard-to-treat bacteria called Pseudomonas aeruginosa. Researchers will compare newer and older antibiotics to see which works best to cure the infection. The goal is to find the most effective treatment for these dangerou…

This study looks at stool samples from 100 critically ill patients to understand how a common bacteria, Pseudomonas aeruginosa, becomes dangerous in the gut. Researchers will test if the gut environment makes the bacteria more harmful. No treatment is given; the goal is to learn …

This study aims to develop new antibody treatments for Pseudomonas aeruginosa, a bacteria that can be resistant to many antibiotics. Researchers will collect blood from 30 patients who have had this infection to isolate and produce antibodies that can fight the bacteria. The goal…